Revenue growth reached 38.2% in 2026Q1, while the company achieved a highly efficient 52.3% combined ratio, suggesting superior underwriting performance compared to traditional regional peers.
| Revenue | 1.26B | 1.16B | 846.81M | 468.53M | 242.43M |
| Revenue Growth % | 35.98% | 36.5% | 80.74% | 93.26% | - |
| Medical Costs & Claims | 234.2M | 235.46M | 425.26M | 251.83M | 166.97M |
| Medical Cost Ratio % | 18.53% | 20.37% | 50.22% | 53.75% | 68.87% |
| Gross Profit | 1.03B | 920.44M | 421.55M | 216.7M | 75.46M |
| Gross Margin % | 81.47% | 79.63% | 49.78% | 46.25% | 31.13% |
| Gross Profit Growth % | - | 118.35% | 94.53% | 187.18% | - |
| Operating Expenses | 378.38M | 331.2M | 151.58M | 99.06M | 45.44M |
| OpEx / Revenue % | 29.94% | 28.65% | 17.9% | 21.14% | 18.74% |
| Depreciation & Amortization | -6.08M | -3.04M | 10.31M | 8.73M | 5.93M |
| Combined Ratio % | 48.48% | 49.02% | 68.12% | 74.89% | 87.62% |
| Operating Income | 651.01M | 589.24M | 269.98M | 117.64M | 30.01M |
| Operating Margin % | 51.52% | 50.98% | 31.88% | 25.11% | 12.38% |
| Operating Income Growth % | - | 118.26% | 129.49% | 291.95% | - |
| EBITDA | 644.93M | 586.2M | 280.29M | 126.37M | 35.95M |
| EBITDA Margin % | 51.04% | 50.71% | 33.1% | 26.97% | 14.83% |
| Interest Expense | 3.55M | 2.7M | 3.75M | 2.4M | 489K |
| Non-Operating Income | -3.55M | -3.63M | -3.75M | -2.4M | -489K |
| Pretax Income | 651.01M | 589.24M | 269.98M | 117.64M | 30.01M |
| Pretax Margin % | 51.52% | 50.98% | 31.88% | 25.11% | 12.38% |
| Income Tax | 160.03M | 145.28M | 68.85M | 30.27M | 7.71M |
| Effective Tax Rate % | 24.58% | 24.66% | 25.5% | 25.73% | 25.7% |
| Net Income | 490.98M | 443.96M | 201.13M | 87.37M | 22.3M |
| Net Margin % | 38.86% | 38.41% | 23.75% | 18.65% | 9.2% |
| Net Income Growth % | 105.51% | 120.74% | 130.2% | 291.82% | - |
| EPS (Diluted) | 3.59 | 3.36 | 1.61 | 0.70 | 1.06 |
| EPS Growth % | 88.48% | 108.7% | 130% | -33.96% | - |
| EPS (Basic) | - | 4.75 | 1.61 | 0.70 | 1.06 |
| Diluted Shares Outstanding | 136.59M | 138.25M | 124.93M | 124.93M | 21.06M |
Florida catastrophe and reinsurance dependency
As reported in recent financial statements, Slide's revenue growth reached 38.2% in 2026Q1, reflecting a sustained expansion strategy that leverages the absorption of policies from exiting Florida carriers to rapidly scale the company's top line in a highly concentrated and competitive regional insurance market.
The consistent double-digit revenue growth suggests that Slide is successfully executing its strategy of capturing market share from distressed incumbents. Investors should monitor whether this pace of expansion remains sustainable without compromising the underlying quality of the risk portfolio as the company reaches a larger scale.
Based on the provided income statement data, Slide achieved a combined ratio of 52.3% in 2026Q1, indicating a robust underwriting profit that appears to significantly outperform traditional Florida-based P&C carriers by maintaining a lean, technology-enabled operational structure that minimizes administrative overhead relative to premium volume.
The exceptionally low combined ratio suggests that the company's data-driven risk selection is effectively mitigating loss exposure. However, analysts should investigate whether these margins are bolstered by favorable reinsurance ceding terms that may not persist if global reinsurance pricing continues to harden.
According to recent SEC filings and industry context, the implementation of Florida Senate Bill 2-A represents a critical inflection point for Slide, as the reduction in litigation-related costs appears to be a primary driver behind the improved loss ratios observed throughout the 2025 and 2026 fiscal periods.
The shift from a 66.8% loss ratio in 2024Q3 to 28.5% in 2026Q1 suggests that the regulatory environment is providing a meaningful tailwind to profitability. This trend warrants further investigation to determine if the improvement is structural or if it remains vulnerable to future shifts in Florida's legal landscape.
While Slide's reported figures show strong profitability, the company's heavy reliance on reinsurance to manage catastrophic risk suggests that its net income may be artificially stabilized by ceding commissions, which warrants caution regarding the true volatility of the underlying insurance book during severe hurricane seasons.
The reliance on third-party capacity implies that any disruption in the reinsurance market could lead to rapid margin compression. Investors should consider that the current profitability profile may be sensitive to external pricing cycles that are largely outside of management's direct control.
Quick answers to the most common questions about buying SLDE stock.
For fiscal year 2025, Slide Insurance Holdings, Inc. Common Stock (SLDE) reported total revenue of $1.16B. This represents a 376.8% increase compared to $242.4M in 2022.
Slide Insurance Holdings, Inc. Common Stock (SLDE) is profitable, generating $444.0M in net income for the fiscal year ending 2025 with a net profit margin of 38.4%.
Slide Insurance Holdings, Inc. Common Stock (SLDE) reported an operating income of $589.2M, resulting in an operating profit margin of 51.0%. This margin reflects the operational efficiency of the business before interest and taxes.
Slide Insurance Holdings, Inc. Common Stock (SLDE) generated $920.4M in gross profit for the year, representing a gross profit margin of 79.6%. This demonstrates the company's core pricing power and production efficiency.